Asia Pacific Scientific Forum: Bench to Bedside to Community and the 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention
April 23-26, 2002
Hawai’i Convention Center
The American Heart Association gratefully acknowledges the educational grant provided for the support of this conference by the members of the American Heart Association Pharmaceutical Roundtable: AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., Inc., Novartis, Pfizer, Inc., Takeda, and Wyeth.
The following companies and organizations made additional contributions to support the conference: Abbott Laboratories, American Heart Association Industry Nutrition Advisory Panel, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Guidant Corporation, Hawaii Medical Service Association, Merck & Co., Inc., North Hawaii Community Hospital, Novartis, Pfizer, Inc., and Sanofi Synthelabo Inc.
It is the mission of the American Heart Association to reduce disability and death from cardiovascular disease and stroke.
For online information, see www.americanheart.org/asianpacific; e-mail email@example.com
Abstracts for the Asia Pacific Scientific Forum: Bench to Bedside to Community and the 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention can be found at the following URL: http://www.americanheart.org/asianpacific.